Lung Cancer Screening With Low-Dose CT

There was a higher remission rate in the pharmacogenomics group at 8 and 12 weeks, but there was no difference at 4, 18, or 24 weeks. So even though prescribing antidepressants based on individualized pharmacogenomic data reduces the potential for drug gene interactions, it doesn't seem to make a difference in the patient-oriented outcome that we care about,. The American College of Chess Physicians has updated its practice guideline on lung cancer screening.